vs
PROG Holdings, Inc.（PRG）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
PROG Holdings, Inc.的季度营收约是Royalty Pharma plc的1.0倍（$651.6M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 5.5%，领先28.9%），PROG Holdings, Inc.同比增速更快（457.1% vs 4.8%），过去两年PROG Holdings, Inc.的营收复合增速更高（4.9% vs 4.6%）
PROG Holdings是一家总部位于美国的金融科技企业，主要面向美国本土市场提供灵活的租购及销售点融资解决方案，核心业务涵盖零售合作伙伴融资、消费信贷与支付服务，帮助消费者无需满足传统信用要求即可购买电子产品、家居用品等商品。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
PRG vs RPRX — 直观对比
营收规模更大
PRG
是对方的1.0倍
$622.0M
营收增速更快
PRG
高出452.3%
4.8%
净利率更高
RPRX
高出28.9%
5.5%
两年增速更快
PRG
近两年复合增速
4.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $651.6M | $622.0M |
| 净利润 | $36.1M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 10.0% | 62.4% |
| 净利率 | 5.5% | 34.4% |
| 营收同比 | 457.1% | 4.8% |
| 净利润同比 | 3.8% | 2.9% |
| 每股收益（稀释后） | $3.68 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRGRPRX
| Q1 26 | $651.6M | — | ||
| Q4 25 | $525.4M | $622.0M | ||
| Q3 25 | $595.1M | $609.3M | ||
| Q2 25 | $604.7M | $578.7M | ||
| Q1 25 | $684.1M | $568.2M | ||
| Q4 24 | $558.9M | $593.6M | ||
| Q3 24 | $606.1M | $564.7M | ||
| Q2 24 | $592.2M | $537.3M |
净利润PRGRPRX
| Q1 26 | $36.1M | — | ||
| Q4 25 | $40.5M | $214.2M | ||
| Q3 25 | $33.1M | $288.2M | ||
| Q2 25 | $38.5M | $30.2M | ||
| Q1 25 | $34.7M | $238.3M | ||
| Q4 24 | $57.5M | $208.2M | ||
| Q3 24 | $84.0M | $544.0M | ||
| Q2 24 | $33.8M | $102.0M |
营业利润率PRGRPRX
| Q1 26 | 10.0% | — | ||
| Q4 25 | 6.9% | 62.4% | ||
| Q3 25 | 9.0% | 70.1% | ||
| Q2 25 | 10.0% | 36.3% | ||
| Q1 25 | 8.2% | 94.0% | ||
| Q4 24 | 8.9% | 60.9% | ||
| Q3 24 | 8.1% | — | ||
| Q2 24 | 9.4% | 50.2% |
净利率PRGRPRX
| Q1 26 | 5.5% | — | ||
| Q4 25 | 7.7% | 34.4% | ||
| Q3 25 | 5.6% | 47.3% | ||
| Q2 25 | 6.4% | 5.2% | ||
| Q1 25 | 5.1% | 41.9% | ||
| Q4 24 | 10.3% | 35.1% | ||
| Q3 24 | 13.9% | 96.3% | ||
| Q2 24 | 5.7% | 19.0% |
每股收益（稀释后）PRGRPRX
| Q1 26 | $3.68 | — | ||
| Q4 25 | $0.99 | $0.49 | ||
| Q3 25 | $0.82 | $0.67 | ||
| Q2 25 | $0.95 | $0.07 | ||
| Q1 25 | $0.83 | $0.55 | ||
| Q4 24 | $1.33 | $0.46 | ||
| Q3 24 | $1.94 | $1.21 | ||
| Q2 24 | $0.77 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $69.4M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $774.4M | $9.7B |
| 总资产 | $2.0B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资PRGRPRX
| Q1 26 | $69.4M | — | ||
| Q4 25 | $308.8M | $618.7M | ||
| Q3 25 | $292.6M | $938.9M | ||
| Q2 25 | $222.0M | $631.9M | ||
| Q1 25 | $213.3M | $1.1B | ||
| Q4 24 | $90.9M | $929.0M | ||
| Q3 24 | $221.7M | $950.1M | ||
| Q2 24 | $250.1M | $1.8B |
总债务PRGRPRX
| Q1 26 | — | — | ||
| Q4 25 | $594.9M | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $643.6M | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B |
股东权益PRGRPRX
| Q1 26 | $774.4M | — | ||
| Q4 25 | $746.4M | $9.7B | ||
| Q3 25 | $703.6M | $9.6B | ||
| Q2 25 | $668.7M | $9.5B | ||
| Q1 25 | $654.4M | $9.8B | ||
| Q4 24 | $650.3M | $10.3B | ||
| Q3 24 | $630.8M | $10.3B | ||
| Q2 24 | $581.9M | $9.8B |
总资产PRGRPRX
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.6B | $19.6B | ||
| Q3 25 | $1.5B | $19.3B | ||
| Q2 25 | $1.5B | $18.3B | ||
| Q1 25 | $1.5B | $17.6B | ||
| Q4 24 | $1.5B | $18.2B | ||
| Q3 24 | $1.4B | $18.0B | ||
| Q2 24 | $1.5B | $17.7B |
负债/权益比PRGRPRX
| Q1 26 | — | — | ||
| Q4 25 | 0.80× | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 0.99× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PRGRPRX
| Q1 26 | — | — | ||
| Q4 25 | $-54.9M | $827.1M | ||
| Q3 25 | $110.0M | $702.6M | ||
| Q2 25 | $69.9M | $364.0M | ||
| Q1 25 | $209.9M | $596.1M | ||
| Q4 24 | $-84.5M | $742.5M | ||
| Q3 24 | $31.9M | $703.6M | ||
| Q2 24 | $55.4M | $658.2M |
自由现金流PRGRPRX
| Q1 26 | — | — | ||
| Q4 25 | $-57.5M | — | ||
| Q3 25 | $106.5M | — | ||
| Q2 25 | $68.0M | — | ||
| Q1 25 | $208.0M | — | ||
| Q4 24 | $-86.8M | — | ||
| Q3 24 | $29.8M | — | ||
| Q2 24 | $53.5M | — |
自由现金流率PRGRPRX
| Q1 26 | — | — | ||
| Q4 25 | -10.9% | — | ||
| Q3 25 | 17.9% | — | ||
| Q2 25 | 11.2% | — | ||
| Q1 25 | 30.4% | — | ||
| Q4 24 | -15.5% | — | ||
| Q3 24 | 4.9% | — | ||
| Q2 24 | 9.0% | — |
资本支出强度PRGRPRX
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.3% | — |
现金转化率PRGRPRX
| Q1 26 | — | — | ||
| Q4 25 | -1.36× | 3.86× | ||
| Q3 25 | 3.32× | 2.44× | ||
| Q2 25 | 1.82× | 12.06× | ||
| Q1 25 | 6.05× | 2.50× | ||
| Q4 24 | -1.47× | 3.57× | ||
| Q3 24 | 0.38× | 1.29× | ||
| Q2 24 | 1.64× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRG
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
